SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-22-000011
Filing Date
2022-03-01
Accepted
2022-03-01 17:04:11
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164617221607889.html 4  
1 FORM 4 wf-form4_164617221607889.xml 4 4139
  Complete submission text file 0001824293-22-000011.txt   5573
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 N. 18TH STREET SUITE 300 PHILADELPHIA PA 19103
Business Address
Baker David Charles (Reporting) CIK: 0001844060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 22699434